Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:24 PM UTC
| NCT Number | NCT06422143 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 851 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06422143 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 22 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06422143 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06422143 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.